Component

Biallelic ALDH7A1 disease genotypes studied by Mills 2006

Biallelic ALDH7A1 disease genotypes studied by Mills 2006

2 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What it acts on

  1. The antiquitin defect was linked to accumulation of alpha-AASA/P6C in the lysine degradation pathway.

    Experimental context and source evidence
    availability_state
    machinery_impairment Imported condition classification; unverified.
    cross_nutrient
    Lysine catabolism generates the metabolite that can sequester PLP.
    experimental_model
    Affected children, expressed human ALDH7A1 variants and metabolite chemistry
    exposure
    ALDH7A1-associated disease and metabolite analysis.
    limitations
    This is inherited pathway failure, not lysine toxicity in healthy people.
    nutrient_topic
    Vitamin B6 research collection; topical membership is not evidence of a direct dietary effect. · Vitamin B6
    organism
    Homo sapiens
    plain_language
    A blocked lysine pathway builds up B6-reactive metabolites.
    primary_references
    [mills-2006-aldh7a1] Mutations in antiquitin in individuals with pyridoxine-dependent seizures (2006). https://doi.org/10.1038/nm1366 DOI: 10.1038/nm1366
    tissue_or_cell_type
    Patient biological samples and biochemical pathway analysis
    trigger_kind
    machinery_impairment Imported condition classification; unverified.

    Vitamin B6: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 1158–1169

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Affected children, expressed human ALDH7A1 variants and metabolite chemistry · source_derived_draft · unverified_draft

    ### b6-neuro-aldh7a1-metabolite-accumulation The antiquitin defect was linked to accumulation of alpha-AASA/P6C in the lysine degradation pathway. Condition category: machinery_impairment nutrient_topic: Vitamin B6 research collection; topical membership is not evidence of a direct dietary effect. plain_language: A blocked lysine pathway builds up B6-reactive metabolites. organism: Homo sapiens tissue_or_cell_type: Patient biological samples and biochemical pathway analysis experimental_model: Affected children, expressed human ALDH7A1 variants and metabolite chemistry limitations: This is inherited pathway failure, not lysine toxicity in healthy people. exposure: ALDH7A1-associated disease and metabolite analysis. cross_nutrient: Lysine catabolism generates the metabolite that can sequester PLP. [mills-2006-aldh7a1] Mutations in antiquitin in individuals with pyridoxine-dependent seizures (2006). https://doi.org/10.1038/nm1366 DOI: 10.1038/nm1366
    Complete structured claim and evidence
  2. ALDH7A1 variants identified in affected children abolished antiquitin activity in the reported functional assays.

    Experimental context and source evidence
    availability_state
    machinery_impairment Imported condition classification; unverified.
    cross_nutrient
    Lysine catabolic machinery can impair intracellular B6 availability.
    experimental_model
    Affected children, expressed human ALDH7A1 variants and metabolite chemistry
    exposure
    Disease-variant functional expression.
    limitations
    Applies to the studied variants; not all possible ALDH7A1 alleles.
    nutrient_topic
    Vitamin B6 research collection; topical membership is not evidence of a direct dietary effect. · Vitamin B6
    organism
    Homo sapiens
    plain_language
    The inherited defect blocks a lysine-breakdown enzyme.
    primary_references
    [mills-2006-aldh7a1] Mutations in antiquitin in individuals with pyridoxine-dependent seizures (2006). https://doi.org/10.1038/nm1366 DOI: 10.1038/nm1366
    tissue_or_cell_type
    Patient-linked expression experiments
    trigger_kind
    machinery_impairment Imported condition classification; unverified.

    Vitamin B6: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 1145–1156

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Affected children, expressed human ALDH7A1 variants and metabolite chemistry · source_derived_draft · unverified_draft

    ### b6-neuro-aldh7a1-variants ALDH7A1 variants identified in affected children abolished antiquitin activity in the reported functional assays. Condition category: machinery_impairment nutrient_topic: Vitamin B6 research collection; topical membership is not evidence of a direct dietary effect. plain_language: The inherited defect blocks a lysine-breakdown enzyme. organism: Homo sapiens tissue_or_cell_type: Patient-linked expression experiments experimental_model: Affected children, expressed human ALDH7A1 variants and metabolite chemistry limitations: Applies to the studied variants; not all possible ALDH7A1 alleles. exposure: Disease-variant functional expression. cross_nutrient: Lysine catabolic machinery can impair intracellular B6 availability. [mills-2006-aldh7a1] Mutations in antiquitin in individuals with pyridoxine-dependent seizures (2006). https://doi.org/10.1038/nm1366 DOI: 10.1038/nm1366
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards